Form 4: Medtronic Executive Matthew R. Walter Reports Stock Transactions

Matthew R. Walter, SVP and Chief HR Officer of Medtronic, reports the acquisition and disposal of ordinary shares and stock options on January 27, 2025.

Summary

• On January 27, 2025, Matthew R. Walter, SVP and Chief HR Officer of Medtronic, engaged in transactions involving Medtronic plc ordinary shares and stock options.
• Walter acquired 1,337 ordinary shares through the exercise of stock options at a price of $74.84.
• He also disposed of 1,174 ordinary shares at a price of $92.46.
• Following these transactions, Walter directly owns 25,823 ordinary shares.
• The reported transactions also include the exercise of stock options (right to buy) for 1,337 shares at $74.84, which were exercisable from January 27, 2016, and expired on January 27, 2025.
• Walter's holdings include shares acquired through dividend reinvestment (205 shares) and Medtronic's Employee Stock Ownership Plan (7 shares) since the last report.

Sentiment

Score: 6

Explanation: Neutral sentiment. The transactions are part of routine executive compensation and do not necessarily indicate a strong positive or negative outlook.

Positives

• The reporting person exercised stock options, indicating confidence in the company's future performance.

Negatives

• The reporting person disposed of shares, which could be interpreted negatively by some investors, although it is a relatively small portion of their holdings.

Risks

• Executive stock transactions can sometimes be misinterpreted by the market, leading to short-term price volatility.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's value and future prospects.

Comparison to Industry Standards

• Executive compensation packages, including stock options, are standard practice among large, publicly traded companies like Medtronic.
• The exercise and disposal of shares are typical activities for executives holding stock options, often timed around vesting schedules and personal financial planning.
• Comparable companies such as Johnson & Johnson (JNJ) and Abbott Laboratories (ABT) also see regular Form 4 filings from their executives.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the potential for short-term price fluctuations.
• The transactions have no direct impact on employees, customers, suppliers, or creditors.

Key Dates